» Articles » PMID: 23935202

Importance of Toxin A, Toxin B, and CDT in Virulence of an Epidemic Clostridium Difficile Strain

Overview
Journal J Infect Dis
Date 2013 Aug 13
PMID 23935202
Citations 112
Authors
Affiliations
Soon will be listed here.
Abstract

Clostridium difficile infection is the main cause of healthcare-acquired diarrhea in the developed world. In addition to the main virulence factors toxin A and B, epidemic, PCR Ribotype 027 strains, such as R20291, produce a third toxin, CDT. To develop effective medical countermeasures, it is important to understand the importance of each toxin. Accordingly, we created all possible combinations of isogenic toxin mutants of R20291 and assessed their virulence. We demonstrated that either toxin A or toxin B alone can cause fulminant disease in the hamster infection model and present tantalizing data that C. difficile toxin may also contribute to virulence.

Citing Articles

major toxins remodel the intestinal epithelia, affecting spore adherence/internalization into intestinal tissue and their association with gut vitronectin.

Castro-Cordova P, Lopez-Garcia O, Orozco J, Montes-Bravo N, Gil F, Pizarro-Guajardo M bioRxiv. 2025; .

PMID: 39974910 PMC: 11838273. DOI: 10.1101/2025.01.29.635439.


Polysaccharide lyase PL3.3 possibly potentiating Clostridioides difficile clinical symptoms based on complete genome analysis of RT046/ST35 and RT012/ST54.

Zhang S, Ma W, Zhang X, Cui W, Liu Y, Tian X Int Microbiol. 2025; .

PMID: 39833587 DOI: 10.1007/s10123-025-00634-x.


The N-terminus of the transferase A component directs toxin activity and potency.

Mullard R, Sheedlo M mBio. 2024; 16(1):e0240524.

PMID: 39611841 PMC: 11708034. DOI: 10.1128/mbio.02405-24.


De novo design of mini-protein binders broadly neutralizing Clostridioides difficile toxin B variants.

Lv X, Zhang Y, Sun K, Yang Q, Luo J, Tao L Nat Commun. 2024; 15(1):8521.

PMID: 39358329 PMC: 11447207. DOI: 10.1038/s41467-024-52582-1.


A monoclonal antibody collection for C. difficile typing ?.

Hunault L, England P, Barbut F, Iannascoli B, Godon O, Dejardin F Gut Pathog. 2024; 16(1):4.

PMID: 38243246 PMC: 10797914. DOI: 10.1186/s13099-023-00592-7.


References
1.
Popoff M, Rubin E, Gill D, Boquet P . Actin-specific ADP-ribosyltransferase produced by a Clostridium difficile strain. Infect Immun. 1988; 56(9):2299-306. PMC: 259564. DOI: 10.1128/iai.56.9.2299-2306.1988. View

2.
Kuehne S, Minton N . ClosTron-mediated engineering of Clostridium. Bioengineered. 2012; 3(4):247-54. PMC: 3476875. DOI: 10.4161/bioe.21004. View

3.
Cartman S, Heap J, Kuehne S, Cockayne A, Minton N . The emergence of 'hypervirulence' in Clostridium difficile. Int J Med Microbiol. 2010; 300(6):387-95. DOI: 10.1016/j.ijmm.2010.04.008. View

4.
McEllistrem M, Carman R, Gerding D, Genheimer C, Zheng L . A hospital outbreak of Clostridium difficile disease associated with isolates carrying binary toxin genes. Clin Infect Dis. 2005; 40(2):265-72. DOI: 10.1086/427113. View

5.
Geric B, Carman R, Rupnik M, Genheimer C, Sambol S, Lyerly D . Binary toxin-producing, large clostridial toxin-negative Clostridium difficile strains are enterotoxic but do not cause disease in hamsters. J Infect Dis. 2006; 193(8):1143-50. DOI: 10.1086/501368. View